Ave. 31 No. 15802 between 158 y 190, Cubanacán, Playa, Havana. C.P. 11600, P.O. Box 6162
webmaster@cigb.edu.cu
(53) 7-2504101; (53) 7-2716022
HOME
ABOUT US
History
Directors
Headquarters
Processes
Research Areas
Events
PRODUCTS
Diagnostic tests
Vaccines
Biopharmaceutical products
Animal Products
Plant Products
Against COVID-19
AGAINST COVID-19
R&D
Biomedical projects
Animal biotechnology projects
Plant biotechnology projects
FAQ
English
Español
English
Noticias
septiembre 2021
29
Sep
The Abdala vaccine is 90% effective in critically ill patients, even with circulation of the Delta strain
0
mf
29
Sep
In Cuba, 30 million doses of the Abdala vaccine have been manufactured
0
mf
20
Sep
Vietnam and Cuba strengthen ties in the field of biotechnology
0
mf
17
Sep
To WHO/PAHO, Cuba presents results in the development of anti-COVID-19 vaccines
0
ga
16
Sep
Cuba presents the results of its covid-19 vaccines to the WHO
0
mf
07
Sep
International certification of Heberbiovac HB®, recombinant vaccine against Hepatitis B
0
